Medical Bulletin 16/February/2023 Isra Zaman16 Feb 2023 3:38 PM ISTHere are the top medical news for the day:Study finds neoadjuvant nivolumab to show long-term benefit in patients with non-small cell lung...
Study finds neoadjuvant nivolumab to show long-term benefit in patients with non-small cell lung cancer Isra Zaman16 Feb 2023 9:00 AM ISTBackground: NSCLC is the most common type of lung cancer and is a leading cause of cancer-related death worldwide. Bottom Line: Patients with...
Medical Bulletin 15/February/2023 Isra Zaman15 Feb 2023 3:36 PM ISTHere are the top medical news for the day:Brain ageing hastened by cocaine addiction: StudyNow, scientists from Germany and Canada have shown that in...
Judge indicates intention to dismiss JnJ talc unit bankruptcy Ruchika Sharma15 Feb 2023 3:15 PM ISTLTL's bankruptcy had put the deluge of talc cases on hold.
Methotrexate use linked with increased risk of skin cancer Dr. Kamal Kant Kohli15 Feb 2023 9:30 AM ISTSweden: The use of methotrexate (MTX), an immunosuppressive drug, is associated with an increased risk of cutaneous squamous cell carcinoma (cSCC),...
Novel urine test to diagnose cancer developed Isra Zaman15 Feb 2023 9:15 AM ISTIn a recent study researchers tried to find metabolites in urine. They succeeded in developing a strip-type urine sensor that can amplify the light...
Medical Bulletin 14/February/2023 Isra Zaman14 Feb 2023 4:05 PM ISTHere are the top medical news for the day:MIT and Caltech engineers demonstrate Ingestible sensor that could help doctors pinpoint GI difficultiesGI...
New target for treatment resistance after EGFR inhibitors found in lung cancer study Isra Zaman14 Feb 2023 9:15 AM ISTApproximately 10-15% of patients with NSCLC have EGFR mutations. While treatment with EGFR TKIs is effective at killing most cancer cells, a small...
Natco Pharma announces submission of ANDA with USFDA for generic version of Olaparib Tablets Ruchika Sharma13 Feb 2023 12:25 PM ISTOlaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer.
Biocon partner Viatris gets Complete Response Letter from USFDA for Bevacizumab license application Ruchika Sharma13 Feb 2023 11:13 AM ISTBevacizumab is a medication used to treat a number of types of cancers and a specific eye disease.
Declining PSA levels after enzalutamide treatment predict longer survival in high risk prostate cancer patients Dr. Kamal Kant Kohli12 Feb 2023 8:00 PM ISTResearchers have found in a new study that falling PSA levels predict longer survival in prostate cancer patients at high risk of metastases.Declines...
Johnson & Johnson MedTech India, Karkinos collaborate to upskill healthcare professionals in cancer care Ruchika Sharma12 Feb 2023 11:30 AM ISTMumbai: Johnson & Johnson MedTech India has announced a collaboration with Karkinos Healthcare, an end-to-end technology platform, to pursue...
